Absorption |
Blood-Brain Barrier | BBB- | 0.8894 |
Human Intestinal Absorption | HIA+ | 0.6887 |
Caco-2 Permeability | Caco2- | 0.6302 |
P-glycoprotein Substrate | Substrate | 0.5934 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8724 |
Non-inhibitor | 0.7211 |
Renal Organic Cation Transporter | Non-inhibitor | 0.6480 |
Distribution |
Subcellular localization | Mitochondria | 0.7945 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7865 |
CYP450 2D6 Substrate | Non-substrate | 0.8558 |
CYP450 3A4 Substrate | Non-substrate | 0.6222 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6515 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8492 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5297 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9349 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8979 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8955 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.5231 |
Non-inhibitor | 0.7896 |
AMES Toxicity | Non AMES toxic | 0.7150 |
Carcinogens | Non-carcinogens | 0.9056 |
Fish Toxicity | High FHMT | 0.6004 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6840 |
Honey Bee Toxicity | Low HBT | 0.6396 |
Biodegradation | Ready biodegradable | 0.5644 |
Acute Oral Toxicity | III | 0.6688 |
Carcinogenicity (Three-class) | Non-required | 0.7367 |